A condensed-cyclic compound represented by Formula 1 and an organic light-emitting device including the condensed-cyclic compound. ##STR00001##
wherein R.sub.1 to R.sub.10 are defined as in the specification.

A condensed-cyclic compound represented by Formula 1 and an organic light-emitting device including the condensed-cyclic compound. ##STR00001##
wherein R.sub.1 to R.sub.10 are defined as in the specification.

Provided are a compound for an organic optoelectric device represented by Chemical Formula 1, an organic light emitting diode including the same, and a display device including the organic light emitting diode. The structure of the compound for an organic optoelectric device represented by Chemical Formula 1 is described in the specification. The compound for an organic photoelectric device provides an organic light emitting diode having excellent electrochemical and thermal stability and improved life-span characteristics, and high luminous efficiency at a low driving voltage, and the compound for an organic photoelectric device may be appropriate for a solution process.

Provided are a compound for an organic optoelectric device represented by Chemical Formula 1, an organic light emitting diode including the same, and a display device including the organic light emitting diode. The structure of the compound for an organic optoelectric device represented by Chemical Formula 1 is described in the specification. The compound for an organic photoelectric device provides an organic light emitting diode having excellent electrochemical and thermal stability and improved life-span characteristics, and high luminous efficiency at a low driving voltage, and the compound for an organic photoelectric device may be appropriate for a solution process.

Disclosed herein are secondary amine compounds that inhibit tRNA synthetase. The compounds of the invention are useful in inhibiting tRNA synthetase in Gram-negative bacteria and are useful in killing Gram-negative bacteria. The secondary amine compounds of the invention are also useful in the treatment of tuberculosis.

Disclosed herein are secondary amine compounds that inhibit tRNA synthetase. The compounds of the invention are useful in inhibiting tRNA synthetase in Gram-negative bacteria and are useful in killing Gram-negative bacteria. The secondary amine compounds of the invention are also useful in the treatment of tuberculosis.

Provided are a method of preparing a malononitrile oxime ether compound and an intermediate compound. The malononitrile oxime ether compound has a structure as shown in formula (VII), wherein W is selected from aryl or heteroaryl. The preparation method comprises steps: reacting a first raw material with a second raw material in the presence of a first solvent and a catalyst to obtain the intermediate compound, wherein the first raw material has a structure as shown in formula (IV), and the second raw material has a structure as shown in formula (V); and subjecting the intermediate compound as shown in formula (VI), and, a dehyclrant to a dehydrantion reaction in the presence of a second solvent to obtain the malononitrile oxime ether compound. In the preparation process for the intermediate, a cheaper cyanoacetamide is used as a raw material, the reaction conditions are mild. Moreover, the yield of the intermediate compound is high and the cost of the process is low. Furthermore, the required malononitrile oxime ether compound, is obtained only through one-step dehydration reaction. Using the preparation method, is advantageous for improving the yield of malononitrile oxime ethers and reducing the cost of the process.

##STR00001##

An AdipoR activator for activating both AdipoR1 and AdipoR2 is provided. A compound represented by the following formula (1), wherein A is a substituted or unsubstituted aryl group or the like, Y.sup.1 is (CHR.sup.2).sub.a— or the like, X is CH or N, R.sup.1 is a C.sub.1-7 alkyl group, m is an integer of 0-4, Y.sup.2 is *—O—CH.sub.2—CONH—, *—CONH—(CH.sub.2).sub.b—CO— or the like, Z is a cyclic group, B may be a substituent of the cyclic group represented by Z, and n is an integer of 0-3.

##STR00001##

An AdipoR activator for activating both AdipoR1 and AdipoR2 is provided. A compound represented by the following formula (1), wherein A is a substituted or unsubstituted aryl group or the like, Y.sup.1 is (CHR.sup.2).sub.a— or the like, X is CH or N, R.sup.1 is a C.sub.1-7 alkyl group, m is an integer of 0-4, Y.sup.2 is *—O—CH.sub.2—CONH—, *—CONH—(CH.sub.2).sub.b—CO— or the like, Z is a cyclic group, B may be a substituent of the cyclic group represented by Z, and n is an integer of 0-3.

##STR00001##

A pyrene compound and an organic light emitting diode device including the same are disclosed. The organic light emitting diode device includes at least two stacks provided between a first electrode and a second electrode, and a charge generation layer provided between the stacks and including an N type charge generation layer and a P type charge generation layer, wherein the N type charge generation layer is made of the pyrene compound.